The global microbial fermentation APIs market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for antibiotics and other microbial fermentation APIs in hospitals, research & academic laboratories, pharmaceutical & biotechnology companies, and others.
Antibiotics are one of the most commonly used types of microbial fermentation APIs in hospitals and research & academic laboratories. Antibiotics are used as a treatment for bacterial infections caused by bacteria such as Staphylococcus aureus (MRSA), Streptococcus pneumoniae (pneumonia), Escherichia coli (E-coli) among others. Amino acids are also widely used in hospitals and research & academic laboratories for various purposes such as improving muscle function or treating liver disease among others. Vitamin is another type of microbial fermentation API that has been widely used in hospitals and research & academic laboratories for various purposes such as preventing vitamin deficiency or treating anemia among others. Nucleotide is another type of microbial fermentation API that has been widely used in hospitals and research & academic laboratories for various purposes such as improving immune system function or treating cancer among others. Organic acid is another type of microbial fermentation API that has been widely used in pharmaceuticals industry due to its ability to produce organic acids which can be converted into drugs with therapeutic properties like anti-inflammatory agents or anti-cancer drugs among others.
-The global market for microbial fermentation APIs is expected to grow at a CAGR of 5.5% from 2017 to 2022.
-The growth of this market is driven by the increasing demand for pharmaceuticals and biotechnology products.
-Increasing research and development activities in the field of biotechnology will also drive this market's growth.
-The increasing number of mergers and acquisitions in the pharmaceutical industry will also fuel this market's growth as it leads to increased product launches by companies looking to expand their product portfolio or enter new markets.
Industry Growth Insights published a new data on “Microbial Fermentation APIs Market”. The research report is titled “Microbial Fermentation APIs Market research by Types (Antibiotics, Amino acids, Vitamin, Nucleotide, Organic acid, Alcohol, Biological products, Hormone, ), By Applications (Hospitals, Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies, ), By Players/Companies Merck, Ajinomoto, HGPF, Huaxing, North China Pharmaceutical, Topfond, DSM, Tianyao, CSPC Pharma, Northeast Pharm, Lukang Pharmaceutical, Luwei Pharmaceutical, Jiangshan (DSM)”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Microbial Fermentation APIs Market Research Report
By Type
Antibiotics, Amino acids, Vitamin, Nucleotide, Organic acid, Alcohol, Biological products, Hormone,
By Application
Hospitals, Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies,
By Companies
Merck, Ajinomoto, HGPF, Huaxing, North China Pharmaceutical, Topfond, DSM, Tianyao, CSPC Pharma, Northeast Pharm, Lukang Pharmaceutical, Luwei Pharmaceutical, Jiangshan (DSM)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Microbial Fermentation APIs Market Report Segments:
The global Microbial Fermentation APIs market is segmented on the basis of:
Types
Antibiotics, Amino acids, Vitamin, Nucleotide, Organic acid, Alcohol, Biological products, Hormone,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Ajinomoto
- HGPF
- Huaxing
- North China Pharmaceutical
- Topfond
- DSM
- Tianyao
- CSPC Pharma
- Northeast Pharm
- Lukang Pharmaceutical
- Luwei Pharmaceutical
- Jiangshan (DSM)
Highlights of The Microbial Fermentation APIs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibiotics
- Amino acids
- Vitamin
- Nucleotide
- Organic acid
- Alcohol
- Biological products
- Hormone
- By Application:
- Hospitals
- Research & Academic Laboratories
- Pharmaceutical & Biotechnology Companies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Microbial Fermentation APIs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Microbial fermentation APIs are a type of technology that allow for the rapid and accurate identification of microbial strains. These APIs can be used to help researchers identify specific microbes, as well as their metabolites and enzymes.
Some of the key players operating in the microbial fermentation apis market are Merck, Ajinomoto, HGPF, Huaxing, North China Pharmaceutical, Topfond, DSM, Tianyao, CSPC Pharma, Northeast Pharm, Lukang Pharmaceutical, Luwei Pharmaceutical, Jiangshan (DSM).
The microbial fermentation apis market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Microbial Fermentation APIs Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Microbial Fermentation APIs Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Microbial Fermentation APIs Market - Supply Chain
4.5. Global Microbial Fermentation APIs Market Forecast
4.5.1. Microbial Fermentation APIs Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Microbial Fermentation APIs Market Size (000 Units) and Y-o-Y Growth
4.5.3. Microbial Fermentation APIs Market Absolute $ Opportunity
5. Global Microbial Fermentation APIs Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Microbial Fermentation APIs Market Size and Volume Forecast by Type
5.3.1. Antibiotics
5.3.2. Amino acids
5.3.3. Vitamin
5.3.4. Nucleotide
5.3.5. Organic acid
5.3.6. Alcohol
5.3.7. Biological products
5.3.8. Hormone
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Microbial Fermentation APIs Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Microbial Fermentation APIs Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Research & Academic Laboratories
6.3.3. Pharmaceutical & Biotechnology Companies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Microbial Fermentation APIs Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Microbial Fermentation APIs Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Microbial Fermentation APIs Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Microbial Fermentation APIs Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Microbial Fermentation APIs Demand Share Forecast, 2019-2026
9. North America Microbial Fermentation APIs Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Microbial Fermentation APIs Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Microbial Fermentation APIs Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Research & Academic Laboratories
9.4.3. Pharmaceutical & Biotechnology Companies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Microbial Fermentation APIs Market Size and Volume Forecast by Type
9.7.1. Antibiotics
9.7.2. Amino acids
9.7.3. Vitamin
9.7.4. Nucleotide
9.7.5. Organic acid
9.7.6. Alcohol
9.7.7. Biological products
9.7.8. Hormone
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Microbial Fermentation APIs Demand Share Forecast, 2019-2026
10. Latin America Microbial Fermentation APIs Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Microbial Fermentation APIs Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Microbial Fermentation APIs Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Research & Academic Laboratories
10.4.3. Pharmaceutical & Biotechnology Companies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Microbial Fermentation APIs Market Size and Volume Forecast by Type
10.7.1. Antibiotics
10.7.2. Amino acids
10.7.3. Vitamin
10.7.4. Nucleotide
10.7.5. Organic acid
10.7.6. Alcohol
10.7.7. Biological products
10.7.8. Hormone
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Microbial Fermentation APIs Demand Share Forecast, 2019-2026
11. Europe Microbial Fermentation APIs Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Microbial Fermentation APIs Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Microbial Fermentation APIs Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Research & Academic Laboratories
11.4.3. Pharmaceutical & Biotechnology Companies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Microbial Fermentation APIs Market Size and Volume Forecast by Type
11.7.1. Antibiotics
11.7.2. Amino acids
11.7.3. Vitamin
11.7.4. Nucleotide
11.7.5. Organic acid
11.7.6. Alcohol
11.7.7. Biological products
11.7.8. Hormone
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Microbial Fermentation APIs Demand Share, 2019-2026
12. Asia Pacific Microbial Fermentation APIs Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Microbial Fermentation APIs Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Microbial Fermentation APIs Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Research & Academic Laboratories
12.4.3. Pharmaceutical & Biotechnology Companies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Microbial Fermentation APIs Market Size and Volume Forecast by Type
12.7.1. Antibiotics
12.7.2. Amino acids
12.7.3. Vitamin
12.7.4. Nucleotide
12.7.5. Organic acid
12.7.6. Alcohol
12.7.7. Biological products
12.7.8. Hormone
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Microbial Fermentation APIs Demand Share, 2019-2026
13. Middle East & Africa Microbial Fermentation APIs Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Microbial Fermentation APIs Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Microbial Fermentation APIs Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Research & Academic Laboratories
13.4.3. Pharmaceutical & Biotechnology Companies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Microbial Fermentation APIs Market Size and Volume Forecast by Type
13.7.1. Antibiotics
13.7.2. Amino acids
13.7.3. Vitamin
13.7.4. Nucleotide
13.7.5. Organic acid
13.7.6. Alcohol
13.7.7. Biological products
13.7.8. Hormone
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Microbial Fermentation APIs Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Microbial Fermentation APIs Market: Market Share Analysis
14.2. Microbial Fermentation APIs Distributors and Customers
14.3. Microbial Fermentation APIs Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Merck
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Ajinomoto
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. HGPF
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Huaxing
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. North China Pharmaceutical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Topfond
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. DSM
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Tianyao
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. CSPC Pharma
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Northeast Pharm
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Lukang Pharmaceutical
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Luwei Pharmaceutical
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Jiangshan (DSM)
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
